Rep. Dexter Introduces Bill Giving FDA Power to Recall All Dangerous Drugs
This bill is currently in the early stages of the legislative process after being sent to the House Committee on Energy and Commerce. It is actively moving through the system, but no future hearings or votes have been scheduled yet. There is no companion bill mentioned at this time.
Most bills introduced in the House do not make it past the committee stage unless they have a large number of supporters from both parties.
Small pharmaceutical manufacturers and compounding pharmacies could face new compliance burdens if the FDA exercises expanded mandatory recall authority against their products. While current voluntary recall systems often work, mandatory recall orders could impose sudden costs on small drug makers. On the other hand, the expanded authority also levels the playing field by ensuring all competitors meet the same safety standards.
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes have been recorded for this legislation yet.
Congressman Andy Kim has reintroduced the Protecting Americans from Unsafe Drugs Act, which would provide the FDA with mandatory recall authority for all prescription and over-the-counter drugs. The bill aims to close loopholes that prevent the agency from pulling dangerous products off the market.
The FDA's mandatory recall authority is under scrutiny as companies refuse voluntary recalls. Lawmakers and the Food Safety Caucus are calling for the agency to exercise and expand its power to compel manufacturers to remove unsafe products from the market to protect public health.
Document Type
Congressional Bill
Official Title
Protecting Americans from Unsafe Drugs Act of 2026
Analysis generated by AI. Always verify with official sources.